TCR-based cancer immunotherapy biotech (UK)
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Louis Bacon / Moore | 53 | Added +39% | 274,663 | $8,720,550 | 0.1% |
| Bridgewater | 56 | Added +94% | 36,707 | $1,165,447 | 0.0% |
| Howard Marks / Oaktree | 71 | Trimmed -67% | 833,000 | $766,360 | 0.0% |
| Steve Cohen / Point72 | 76 | Trimmed -10% | 990,280 | $31,441,390 | 0.0% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-09-24.